ET‐1 actions in the kidney: evidence for sex differences
Authors:
- 20 December 2012
- journal article
- review article
- Published by Wiley in British Journal of Pharmacology
- Vol. 168 (2) , 318-326
Abstract
Hypertension and chronic kidney disease are more common in men than in premenopausal women at the same age. In animal models, females are relatively protected against genetic or pharmacological procedures that produce high blood pressure and renal injury. Overactivation or dysfunction of the endothelin (ET) system modulates the progression of hypertension or kidney diseases with the ETAreceptor primarily mediating vasoconstriction, injury and anti‐natriuresis, and ETBreceptors having opposite effects. The purpose of this review is to examine the role of the ET system in the kidney with a focus on the inequality between the sexes associated with the susceptibility to and progression of hypertension and kidney diseases. In most animal models, males have higher renal ET‐1 mRNA expression, greater ETA‐mediated responses, including renal medullary vasoconstriction, and increased renal injury. These differences are reduced following gonadectomy suggesting a role for sex hormones, mainly testosterone. In contrast, females are relatively protected from high blood pressure and kidney damage via increased ETBversus ETAreceptor function. Furthermore, ETAreceptors may have a favourable effect on sodium excretion and reducing renal damage in females. In human studies, the genetic polymorphisms of the ET system are more associated with hypertension and renal injury in women. However, the knowledge of sex differences in the efficacy or adverse events of ETAantagonists in the treatment of hypertension and kidney disease is poorly described. Increased understanding how the ET system acts differently in the kidneys between sexes, especially with regard to receptor subtype function, could lead to better treatments for hypertension and renal disease.LINKED ARTICLESThis article is part of a themed section on Endothelin. To view the other articles in this section visithttp://dx.doi.org/10.1111/bph.2013.168.issue-2Keywords
This publication has 84 references indexed in Scilit:
- Endothelin and the Renal Vasculature2011
- Regulation of Blood Pressure and Salt Homeostasis by EndothelinPhysiological Reviews, 2011
- Autosomal dominant polycystic kidney disease: the last 3 yearsKidney International, 2009
- Contribution of Endothelin A Receptors in Endothelin 1–Dependent Natriuresis in Female RatsHypertension, 2009
- Endothelin-1 Inhibits Thick Ascending Limb Transport via Akt-stimulated Nitric Oxide ProductionJournal of Biological Chemistry, 2009
- Combined knockout of collecting duct endothelin A and B receptors causes hypertension and sodium retentionAmerican Journal of Physiology-Renal Physiology, 2008
- Regulation of the epithelial Na+channel by endothelin-1 in rat collecting ductAmerican Journal of Physiology-Renal Physiology, 2008
- Collecting duct-specific knockout of the endothelin B receptor causes hypertension and sodium retentionAmerican Journal of Physiology-Renal Physiology, 2006
- Collecting duct-specific knockout of the endothelin A receptor alters renal vasopressin responsiveness, but not sodium excretion or blood pressureAmerican Journal of Physiology-Renal Physiology, 2005
- Gender-dependent disease severity in autosomal polycystic kidney disease of ratsKidney International, 1995